BRAIN Biotech AG

About BRAIN Biotech AG

Industrial biotechnology is our profession. Finding solutions for sustainable products and processes is our passion. Together with our customers, we are creating a biobased future.We enable industry partners to make products and processes more sustainable: with optimized enzymes, high-performance microorganisms and bioactive compounds.

  • DE
  • 2024
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Primary activities
Biopharmaceutical
Contract Manufacturer
Contract Research Organisation
Contact info
  • Darmstädterstraße 34-36, Zwingenberg, Germany

Products from BRAIN Biotech AG (2)

  • Enzymes, Enzyme products, and Enzyme Expression Services

    Product Enzymes, Enzyme products, and Enzyme Expression Services

    The BRAIN Biotech Group’s proprietary bioarchive offers access to an immense variety of new biological solutions for sustainable industrial processes and ingredients. The BRAIN BioArchive encompasses microorganisms, natural compounds, fractions obtained from edible plant material, proprietary metagenome an...
  • Microbial Strains and Strain Engineering

    Product Microbial Strains and Strain Engineering

    Our BRAIN Bioarchive provides access to a wealth of new biological solutions for industrial processes and applications. Whether the aim is to utilize different substrates (including CO2), develop novel or alternative biosynthetic products and more stable production strains, identify safe strains and microo...

BRAIN Biotech AG Resources (1)

  • News BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes

    BRAIN Biotech AG and Enzymicals AG are pleased to announce that Dr. Erik de Vries will join BRAIN Biotech as Senior Business Development Director Enzymes as of June 1st, 2024. De Vries will continue in his current position as CEO of Enzymicals AG on a part-time basis during a transition phase until the end of the year. During this transition phase, his activities will already focus on BRAIN Biotech at the Zwingenberg site.